What researchers study
Tirzepatide activates both GIP and GLP-1 receptors. FDA-approved prescription products containing tirzepatide are used for specific indications under medical supervision.
Important: Clinical evidence for an FDA-approved or clinical-trial drug does not establish that an online research product with the same ingredient name is equivalent.
Potential side effects & unknowns
Common adverse effects include gastrointestinal symptoms such as nausea, diarrhea, vomiting and constipation. Approved labeling contains important warnings and contraindications; compounded or unapproved versions do not undergo the same FDA premarket review for safety, quality and effectiveness.
Evidence snapshot
Large randomized trials established clinically meaningful effects on body weight and metabolic outcomes for regulated tirzepatide drug products. Those findings should not be automatically transferred to an online research product with different sourcing or manufacturing controls.